The use of combined pharmacotherapy with impaza and type 5 phosphodiesterase inhibitors helps to prevent and/or considerably reduce the risk of posttraumatic erectile dysfunction in men with traumas and strictures of the urethra. This therapy is indicated at early terms after trauma of the urethra for prophylactics of erectile dysfunction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kh. S. Ibishev, Proceedings of the 3rd Russian Conference “Men Health”. Moscow (2006), p. 198.
M. I. Kogan and Kh. S. Ibishev, Ibid., pp. 164-165.
M. I. Kogan and Kh. S. Ibishev, Progress in the Treatment of Upper Urinary Tract Diseases and Urethral Strictures [in Russoan], Ekaterinburg (2006), p. 410.
M. I. Kogan, Kh. S. Ibishev, and S. I. Sidorenko, Proceedings of XI Russian Urologist Congress [in Russian], Moscow (2007).
Author information
Authors and Affiliations
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 148, Suppl. 1, pp. 71-73, August, 2009
Rights and permissions
About this article
Cite this article
Ibishev, K.S. Efficiency of Combined Therapy with Impaza and Type 5 Phosphodiesterase Inhibitors in Prophylactics of Posttraumatic Erectile Dysfunction. Bull Exp Biol Med 148, 322–324 (2009). https://doi.org/10.1007/s10517-009-0691-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-009-0691-z